Dominant_JJ
cytotoxic_JJ
T_NN
lymphocyte_NN
response_NN
to_TO
the_DT
immediate-early_JJ
trans-activator_NN
protein_NN
,_,
BZLF1_NN
,_,
in_IN
persistent_JJ
type_NN
A_NN
or_CC
B_NN
Epstein-Barr_JJ
virus_NN
infection_NN
._.

Five_CD
healthy_JJ
human_JJ
leukocyte_NN
antigen-B8_NN
-LRB-_-LRB-
HLA-B8_NN
-RRB-_-RRB-
-_:
positive_JJ
virus_NN
carriers_NNS
were_VBD
studied_VBN
to_TO
investigate_VB
the_DT
CD8_NN
+_CC
cytotoxic_JJ
T_NN
lymphocyte_NN
-LRB-_-LRB-
CTL_NN
-RRB-_-RRB-
response_NN
to_TO
an_DT
HLA-B8-restricted_JJ
peptide_NN
,_,
RAKFKQLLQ_NN
,_,
located_JJ
in_IN
the_DT
Epstein-Barr_JJ
virus_NN
-LRB-_-LRB-
EBV_NN
-RRB-_-RRB-
immediate-early_JJ
trans-activator_NN
protein_NN
,_,
BZLF1_NN
._.

Of_IN
the_DT
5_CD
virus_NN
carriers_NNS
,_,
4_CD
were_VBD
infected_VBN
with_IN
type_NN
A_NN
and_CC
1_CD
with_IN
type_NN
B_NN
EBV_NN
._.

Using_VBG
limiting-dilution_JJ
analysis_NN
of_IN
peripheral_JJ
blood_NN
mononuclear_JJ
cells_NNS
,_,
a_DT
high_JJ
RAKFKQLLQ-specific_JJ
CTL_NN
precursor_NN
frequency_NN
was_VBD
demonstrated_VBN
after_IN
specific_JJ
peptide_NN
or_CC
autologous_JJ
lymphoblastoid_JJ
cell_NN
line_NN
stimulation_NN
in_IN
both_CC
type_NN
A_NN
and_CC
type_NN
B_NN
EBV_NN
carriers_NNS
._.

The_DT
RAKFKQLLQ-specific_JJ
CTL_NN
precursor_NN
frequencies_NNS
in_IN
all_DT
5_CD
persons_NNS
were_VBD
at_IN
least_JJS
as_RB
dominant_JJ
as_IN
those_DT
observed_VBN
with_IN
two_CD
other_JJ
EBV-associated_JJ
,_,
HLA-B8-restricted_JJ
latent_JJ
epitopes_NNS
,_,
FLRGRAYGL_NN
and_CC
QAKWRLQTL_NN
._.

These_DT
findings_NNS
show_VBP
that_IN
healthy_JJ
virus_NN
carriers_NNS
maintain_VBP
a_DT
high_JJ
frequency_NN
of_IN
BZLF1-specific_JJ
memory_NN
T_NN
cells_NNS
,_,
potentially_RB
to_TO
control_VB
virus_NN
spread_NN
from_IN
lytically_RB
infected_JJ
cells_NNS
._.

